11 – 20 of 34
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes
(
- Contribution to journal › Scientific review
-
Mark
Proteomic analysis enables distinction of early- versus advanced-stage lung adenocarcinomas
(
- Contribution to journal › Article
- 2019
-
Mark
Challenging the heterogeneity of disease presentation in malignant melanoma—impact on patient treatment
(
- Contribution to journal › Article
-
Mark
Clinical protein science in translational medicine targeting malignant melanoma
(
- Contribution to journal › Article
-
Mark
Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
(
- Contribution to journal › Article
-
Mark
The hidden story of heterogeneous B-raf V600E mutation quantitative protein expression in metastatic melanoma—association with clinical outcome and tumor phenotypes
(
- Contribution to journal › Article
-
Mark
Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease
(
- Contribution to journal › Article
- 2018
-
Mark
Endogenous expression mapping of malignant melanoma by mass spectrometry imaging
(
- Contribution to journal › Article
- 2017
-
Mark
Limited tumor tissue drug penetration contributes to primary resistance against angiogenesis inhibitors
(
- Contribution to journal › Article
- 2015
-
Mark
Association of Chromosome 19 to Lung Cancer Genotypes and Phenotypes
(
- Contribution to journal › Scientific review